• Proteolytic Neuroligin 1 Fragments Sustain Social Memory in

  2026-04-20

  This study elucidates a novel mechanism for the maintenance of social memory by identifying the role of proteolytic products of Neuroligin 1, specifically the NLG1-CTD fragment, in the ventral hippocampus. The findings bridge extracellular proteolytic signaling with intracellular pathways regulating synaptic plasticity, offering new insights into memory processes relevant to neuropsychiatric disorders.

• Mechanisms of Diuron-Induced Acute Renal Injury: JAK2/STAT1

  2026-04-19

  This study integrates network toxicology and experimental validation to elucidate how Diuron induces acute kidney injury via the JAK2/STAT1 signaling pathway. The findings provide mechanistic clarity on Diuron’s nephrotoxicity, supporting future risk assessment and intervention efforts.

• Triiodothyronine: Accelerating Adipocyte Thermogenesis Resea

  2026-04-18

  This article explores the mechanistic and translational impact of Triiodothyronine (T3) in adipose tissue biology—focusing on the intersection of thyroid hormone signaling, beige adipocyte differentiation, and metabolic regulation. Drawing on the latest SEMA3E-β-catenin research and APExBIO's high-purity T3, we provide strategic guidance for researchers advancing metabolic disorder models and related cellular assays.

• TSPAN18-STIM1 Axis Drives Bone Metastasis in Prostate Cancer

  2026-04-17

  Zhou et al. identify TSPAN18 as a novel stabilizer of STIM1, protecting it from TRIM32-mediated degradation and thereby enhancing calcium influx through the STIM1-Ca2+ signaling axis. This mechanism significantly promotes bone metastasis in prostate cancer, highlighting TSPAN18 as a potential therapeutic target and providing new insight into calcium signaling's role in metastatic progression.

• DAPT (GSI-IX): Protocol Optimization for Notch Pathway Resea

  2026-04-16

  DAPT (GSI-IX) is a selective γ-secretase inhibitor that unlocks reproducible control of Notch and amyloid precursor protein processing in cellular and organoid models. This guide translates cutting-edge organoid methodology and real-world troubleshooting into actionable protocols, maximizing the power of DAPT in disease modeling and translational research.

• SB203580: Advancing p38 MAPK Research from Mechanism to Clin

  2026-04-15

  This article unpacks how SB203580 (4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine) empowers translational researchers to dissect the p38 MAPK signaling pathway with mechanistic precision. We blend experimental protocols, recent advances in regenerative urology, and strategic guidance for overcoming translational challenges—differentiating this resource from conventional product pages by connecting the latest mechanistic insights to actionable experimental design.

• Nanoparticle PTEN mRNA Delivery Reverses Trastuzumab Resista

  2026-04-14

  This study introduces a pH-responsive nanoparticle system for systemic delivery of PTEN mRNA, targeting the reversal of trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN and inhibiting persistent PI3K/Akt pathway activation, the approach offers a mechanistically precise strategy for overcoming a major limitation in monoclonal antibody therapy.

• DM-β-Cyclodextrin Modulation of Mianserin HCl Toxicity: Mech

  2026-04-13

  This study systematically investigates the interaction between mianserin hydrochloride (Mianserin HCl), a 5-HT2 receptor antagonist, and heptakis (2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD). Using calorimetry, spectroscopy, and cytotoxicity assays, the authors demonstrate that complexation with DM-β-CD increases Mianserin HCl's cytotoxicity toward mammalian cells, contrasting with previous findings involving non-methylated β-cyclodextrin. These results offer critical guidance for designing inclusion complexes involving antidepressant research compounds.

• Ertapenem Sodium Salt: From Mechanism to Translational Impac

  2026-04-12

  This thought-leadership article examines the mechanistic action, resistance dynamics, and translational utility of Ertapenem (sodium salt) in the face of rising carbapenem-resistant Enterobacteriaceae. Bridging molecular pharmacology and experimental design, the article leverages recent clinical genomics data from Guangdong, China, to guide researchers in building robust resistance studies and advancing the field beyond conventional workflows.

• GRP78-Mediated Stabilization of PD-L1 in Triple-Negative Bre

  2026-04-12

  This study reveals that the ER stress protein GRP78 directly binds and stabilizes PD-L1 in triple-negative breast cancer cells, promoting immune evasion. The findings provide a mechanistic rationale for targeting GRP78 to enhance immunotherapeutic response in aggressive breast cancers.

• Myriocin: Applied Workflows for Sphingolipid Metabolism Rese

  2026-04-11

  Myriocin, a potent serine palmitoyltransferase inhibitor from APExBIO, empowers researchers to dissect sphingolipid metabolism and cell cycle regulation with exceptional specificity. This guide provides validated experimental workflows, advanced troubleshooting strategies, and actionable tips to maximize reproducibility and data quality across oncology, immunology, and metabolic research.

• Applied Native Protein Gel Electrophoresis with K4142 Kit

  2026-04-11

  Unlock efficient, activity-preserving protein separation with the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0). This guide delivers actionable workflows, troubleshooting insights, and cross-validated protocol enhancements for native gel analysis of acidic proteins—bridging advanced research platforms with robust, reproducible results.

• Deferiprone (B1723): Scenario-Driven Guidance for Iron Ch...

  2026-04-10

  This practical, scenario-driven guide addresses common lab challenges in iron-mediated cellular studies, focusing on the use of Deferiprone (SKU B1723) as a validated, reproducible iron-chelating agent. It provides evidence-based Q&A, protocol optimization strategies, and real-world product selection advice for biomedical researchers and technicians leveraging Deferiprone in cancer biology, oxidative stress, and apoptosis assays.

• Deferiprone in Advanced Iron Metabolism and Apoptosis Res...

  2026-04-09

  Explore the multifaceted roles of Deferiprone as an iron-chelating agent in cancer biology and cellular metabolic studies. This in-depth analysis reveals unique insights into iron-dependent signaling modulation, apoptosis induction, and innovative applications in neurovascular and enterocyte models.

• Deferiprone as a Precision Tool for Iron-Dependent Signal...

  2026-04-08

  This thought-leadership article explores how Deferiprone—an iron-chelating agent with high selectivity for ferric ions—redefines experimental approaches to cancer biology, iron metabolism, and neurovascular disease modeling. Drawing on mechanistic studies and recent breakthroughs in enterocyte metabolism, the article offers practical guidance for translational researchers seeking reproducibility and strategic insight into iron-mediated pathways. The discussion uniquely bridges the gap between molecular mechanisms, experimental design, and future applications, and positions APExBIO’s Deferiprone as a benchmark reagent for advanced cellular research.

406 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page